Nicola Dagg
Allen & Overy LLP

Nicola leads Allen & Overy's Intellectual Property Litigation practice in London and is chair of our global life sciences group. She has a degree in Natural Sciences from Cambridge University.

She has considerable experience dealing with the litigious and advisory aspects of matters with a high scientific and technological content and, in particular, with issues in the life sciences sector. She has acted in numerous international patent disputes, as well as in disputes involving trade marks and designs. In addition, she advises on the promotion of pharmaceutical products and data exclusivity and has also worked closely with our leading antitrust specialists, advising on the antitrust defences increasingly forming part of life sciences patent litigation.

Nicola is currently leading a team of Allen & Overy lawyers from London, Paris and Munich in representing Warner-Lambert Company LLC (part of the Pfizer Inc. group of companies) in seeking to enforce their second medical use patent which protects the blockbuster Lyrica® product when used for the treatment of pain.

Nicola is ranked as a leading IP partner in Chambers UK, Legal 500 and IAM Patent 1000.  Nicola has also been selected as one of the 10 “Most Highly Regarded Individuals” in Europe by Who's Who Legal: Patents 2015 and was named as one of the “Top 50 women lawyers in London” in the 2014 Super Lawyers list.